Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study Academic Article uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Atenolol
  • Hemoglobins
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • After adjusting for other risk factors, relatively low, but not high, hemoglobin during antihypertensive treatment was associated with higher incidence of all-cause mortality and the composite end point.

publication date

  • January 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2008.08.011

PubMed ID

  • 19081416

Additional Document Info

start page

  • 177

end page

  • 84

volume

  • 157

number

  • 1